```html

Migraine (Ictal Phase)

What is Migraine (Ictal Phase)?

The ictal phase of migraine is the period when a headache attack is actively occurring. It follows the prodrome (early warning signs) and the aura (visual or sensory phenomena) and precedes the post‑drome (recovery phase). During the ictal phase, the characteristic throbbing or pulsing pain, usually on one side of the head, is at its peak. This phase can last anywhere from 4 to 72 hours if left untreated, and it is the portion of a migraine that most people associate with the “migraine headache.”

Migraine is a neurovascular disorder, meaning that both nerves and blood vessels are involved. Modern research suggests that the ictal phase is driven by a cascade of events that includes cortical spreading depression, activation of the trigeminovascular system, and release of inflammatory neuropeptides such as calcitonin gene‑related peptide (CGRP). These changes cause dilation of blood vessels in the meninges and stimulate pain pathways, producing the intense, often disabling pain of a migraine attack.

Common Causes

While migraine itself is a primary headache disorder (not caused by another disease), several triggers and comorbid conditions can precipitate or worsen the ictal phase. Below are 8–10 of the most frequently reported contributors.

• Hormonal fluctuations – especially estrogen drops before menstruation, during pregnancy, or menopause.
• Sleep disturbances – insufficient sleep, irregular sleep‑wake cycles, or oversleeping.
• Dietary triggers – aged cheese, processed meats, chocolate, caffeine, alcohol (particularly red wine), and foods containing monosodium glutamate (MSG) or aspartame.
• Dehydration – even mild fluid loss can precipitate an attack.
• Stress & emotional strain – acute stress, chronic anxiety, or major life changes.
• Environmental factors – bright or flickering lights, loud noises, strong smells, and changes in barometric pressure.
• Medication overuse – frequent use of acute analgesics (e.g., triptans, NSAIDs) can lead to rebound headaches.
• Physical exertion – intense cardio or weight‑lifting workouts, especially when performed without proper warm‑up.
• Medical conditions – hypothyroidism, anemia, migraine‑associated vertigo, or obstructive sleep apnea.
• Genetic predisposition – a family history of migraine increases susceptibility to attacks.

Identifying personal triggers is a cornerstone of migraine management because avoidance or modification can reduce the frequency and severity of ictal episodes.

Associated Symptoms

During the ictal phase, migraine often presents with a constellation of symptoms beyond head pain. Commonly reported features include:

• Pulsating or throbbing pain – usually unilateral (one side) but can become bilateral.
• Nausea and vomiting – present in up to 70 % of attacks.
• Photophobia – increased sensitivity to light.
• Phonophobia – heightened sensitivity to sound.
• Phonoplagia – discomfort from certain smells (osmophobia).
• Visual disturbances – if an aura precedes the headache, patients may notice zig‑zag lines, blind spots, or flashing lights.
• Neck stiffness or tenderness – often mistaken for tension‑type headache.
• Fatigue and difficulty concentrating – “brain fog” may persist throughout the attack.
• Dizziness or vertigo – especially in migraine‑associated vestibular disorders.

When to See a Doctor

Most migraines can be managed with self‑care and outpatient treatment, but certain red‑flag features warrant prompt medical evaluation.

• Sudden, severe “thunderclap” headache that peaks within 60 seconds.
• New onset migraine after age 50.
• Headache that changes pattern significantly (e.g., more frequent, more intense, or different location).
• Neurological deficits that do not resolve when the headache ends (weakness, numbness, speech problems, vision loss).
• Headache triggered by coughing, sneezing, or straining.
• Fever, stiff neck, or rash accompanying the headache.
• Persistent vomiting that prevents oral medication intake.
• History of immunosuppression, cancer, or recent head trauma.

If any of these occur, seek emergency care or contact your healthcare provider immediately.

Diagnosis

Diagnosing migraine (ictal phase) is primarily clinical, based on a thorough history and physical examination. The International Classification of Headache Disorders, 3rd edition (ICHD‑3) provides criteria that clinicians use.

Key diagnostic steps

1. Detailed symptom diary – recording attack frequency, duration, trigger exposure, associated symptoms, and response to medication.
2. Neurological exam – to rule out focal deficits that suggest secondary causes.
3. Imaging when indicated – MRI or CT scan may be ordered if red‑flag signs are present or if the headache pattern is atypical.
4. Laboratory tests (optional) – CBC, thyroid panel, or iron studies if anemia or hormonal issues are suspected.
5. Screening for comorbidities – depression, anxiety, sleep disorders, and cardiovascular risk factors.

Diagnostic criteria (ICHD‑3)

• At least five attacks fulfilling the following:
• Headache lasting 4–72 hours (untreated or unsuccessfully treated).
• At least two of the following pain characteristics: unilateral location, pulsating quality, moderate‑to‑severe intensity, aggravation by routine physical activity.
• During headache, at least one of: nausea and/or vomiting, photophobia, phonophobia.
• Not better explained by another ICHD‑3 diagnosis.

Treatment Options

Therapy for the ictal phase centers on rapid pain relief, symptom control, and preventing progression to chronic migraine.

Acute (abortive) medications

• Triptans (sumatriptan, rizatriptan, eletriptan, etc.) – 5‑HT1B/1D agonists that abort the attack within 2 hours. Most effective if taken early (during mild/moderate pain).
• NSAIDs (ibuprofen 400‑800 mg, naproxen 500 mg) – reduce inflammation and pain; often combined with a triptan for severe attacks.
• Acetaminophen – useful for mild attacks or when triptans are contraindicated.
• Gepants (ubrogepant, rimegepant) – CGRP receptor antagonists approved for acute treatment; no vasoconstrictive effect, making them safer for patients with cardiovascular disease.
• Ditans (lasmiditan) – selective 5‑HT1F agonist; avoids vasoconstriction but may cause dizziness.
• Anti‑emetics (metoclopramide, prochlorperazine) – for nausea and to enhance oral medication absorption.

Preventive (prophylactic) medications

Considered when migraines are frequent (≥4 days/month), disabling, or when acute meds are overused.

• Beta‑blockers (propranolol, metoprolol) – first‑line for many patients.
• Anticonvulsants (topiramate, valproate) – effective for both migraine with and without aura.
• Tricyclic antidepressants (amitriptyline) – especially useful when comorbid tension‑type headache or insomnia exists.
• CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) – administered monthly or quarterly; high efficacy with few systemic side effects.
• Onabotulinum toxin A – FDA‑approved for chronic migraine (≥15 headache days/month). Injections every 12 weeks.

Home & lifestyle measures

• Cold or warm compress – apply to the forehead or neck.
• Dark, quiet room – reduce photophobia and phonophobia.
• Hydration – drink 500 ml–1 L of water at the onset of an attack.
• Relaxation techniques – deep‑breathing, progressive muscle relaxation, guided imagery.
• Regular meals – avoid skipping meals which can trigger attacks.

Prevention Tips

Even when a patient does not need daily prophylactic medication, behavioral strategies can lower attack frequency.

• Maintain a consistent sleep schedule – aim for 7–9 hours/night; go to bed and wake up at the same time daily.
• Identify and avoid personal triggers – keep a migraine diary for at least 3 months.
• Stay hydrated – target ~2 L of fluids per day, more if exercising or in hot climates.
• Moderate caffeine – limit to ≤200 mg/day and avoid abrupt cessation.
• Exercise regularly – 150 minutes of moderate aerobic activity per week (e.g., brisk walking, cycling).
• Stress‑management programs – cognitive‑behavioral therapy (CBT), mindfulness‑based stress reduction, or yoga.
• Balanced diet – incorporate magnesium‑rich foods (leafy greens, nuts, seeds) and riboflavin (vitamin B2) which have modest preventive evidence.
• Limit medication overuse – keep acute meds to ≤10 days/month for NSAIDs and ≤2 days/month for triptans.
• Hormonal considerations – discuss with a physician if menstrual migraines are severe; options include hormonal contraceptives or perimenstrual prophylaxis.

Emergency Warning Signs

Summary

The ictal phase of migraine represents the active headache period that can be profoundly disabling. Understanding its pathophysiology, common triggers, and associated symptoms helps patients and clinicians tailor effective acute treatment while also implementing preventive strategies to reduce future attacks. Prompt recognition of red‑flag features ensures that serious underlying conditions are not missed.

For personalized guidance, always discuss your migraine pattern with a healthcare professional. Evidence‑based resources such as the Mayo Clinic, American Migraine Foundation, and the International Headache Society provide up‑to‑date recommendations.

References

• Mayo Clinic. “Migraine.” Updated 2023. https://www.mayoclinic.org
• American Headache Society. “ICHD‑3 Classification.” 2022. https://www.ahsonline.org
• National Institute of Neurological Disorders and Stroke (NINDS). “Migraine Information Page.” 2022. https://www.ninds.nih.gov
• Cleveland Clinic. “Migraine Treatment Options.” 2023. https://my.clevelandclinic.org
• World Health Organization. “Headache Disorders.” Fact sheet, 2021. https://www.who.int

```